SpineAlign Medical Inc. is an early-stage medical device company focused on enhancing patient outcomes through the development of innovative, minimally-invasive products for treating spinal disorders. Its first technology, the VerteLift™ Implant, designed to enhance treatment for vertebral compression fractures, is CE marked and commercially distributed in Europe. The implant is currently undergoing an Investigational Device Exemption Trial (IDE Trial) in the United States. The company, established in 2005, operates in the Health Care and Medical Devices industries. Notably, its last funding round amounted to $8.80M, secured through a Venture Round investment on 03 June 2008, with participation from Hatteras Venture Partners and MedFocus Fund. The dedicated SpineAlign Team is committed to advancing minimally invasive treatment of spinal disorders and developing additional technologies to address emerging clinical needs.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | $8.80M | 2 |
|
03 Jun 2008 |
No recent news or press coverage available for SpineAlign Medical.
We care about your data, and we'd love to use cookies make your experience better.
